Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Tuberculosis

Free Subscription Articles published in Emerg Infect Dis Retrieve available abstracts of 105 articles: HTML format

Single Articles

March 2021
1. MALIK AA, Gandhi NR, Lash TL, Cranmer LM, et al
   Effectiveness of Preventive Therapy for Persons Exposed at Home to Drug-Resistant Tuberculosis, Karachi, Pakistan.
   Emerg Infect Dis. 2021;27:805-812.
   PubMed    
   
   
   
2. LAFLEUR M, Reuter KE, Hall MB, Rasoanaivo HH, et al
   Drug-Resistant Tuberculosis in Pet Ring-Tailed Lemur, Madagascar.
   Emerg Infect Dis. 2021;27:977-979.
   PubMed     Abstract available
   
   
   
3. WALTER KS, Tatara MB, Esther da Silva K, Moreira FMF, et al
   Local and Travel-Associated Transmission of Tuberculosis at Central Western Border of Brazil, 2014-2017.
   Emerg Infect Dis. 2021;27:905-914.
   PubMed     Abstract available
   
   
   
4. NGUYEN HV, Nguyen HB, Nguyen NV, Cobelens F, et al
   Decline of Tuberculosis Burden in Vietnam Measured by Consecutive National Surveys, 2007-2017.
   Emerg Infect Dis. 2021;27:872-879.
   PubMed     Abstract available
   
   
   
5. FAROOQ HZ, Cirillo DM, Hillemann D, Wyllie D, et al
   Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs.
   Emerg Infect Dis. 2021;27:985-987.
   PubMed     Abstract available
   
   
   
6. NONGHANPHITHAK D, Chaiprasert A, Smithtikarn S, Kamolwat P, et al
   Clusters of Drug-Resistant Mycobacterium tuberculosis Detected by Whole-Genome Sequence Analysis of Nationwide Sample, Thailand, 2014-2017.
   Emerg Infect Dis. 2021;27:813-822.
   PubMed     Abstract available
   
   
   
7. CUEVAS LE, Santos VS, Lima SVMA, Kontogianni K, et al
   Systematic Review of Pooling Sputum as an Efficient Method for Xpert MTB/RIF Tuberculosis Testing during the COVID-19 Pandemic.
   Emerg Infect Dis. 2021;27:719-727.
   PubMed     Abstract available
   
   
   
8. ZETOLA NM, Moonan PK, Click E, Oeltmann JE, et al
   Population-Based Geospatial and Molecular Epidemiologic Study of Tuberculosis Transmission Dynamics, Botswana, 2012-2016.
   Emerg Infect Dis. 2021;27:835-844.
   PubMed     Abstract available
   
   
   
9. TAZERART F, Saad J, Niar A, Sahraoui N, et al
   Mycobacterium bovis Pulmonary Tuberculosis, Algeria.
   Emerg Infect Dis. 2021;27:972-974.
   PubMed     Abstract available
   
   
   
10. CHITWOOD MH, Pelissari DM, Marques da Silva GD, Bartholomay P, et al
    Trends in Untreated Tuberculosis in Large Municipalities, Brazil, 2008-2017.
    Emerg Infect Dis. 2021;27:957-960.
    PubMed     Abstract available
    
    
    January 2021
11. LEAVITT SV, Jacobson KR, Ragan EJ, Bor J, et al
    Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa.
    Emerg Infect Dis. 2021;27:728-739.
    PubMed     Abstract available
    
    
    December 2020
12. MANDALAKAS AM, Kay AW, Bacha JM, Devezin T, et al
    Tuberculosis among Children and Adolescents at HIV Treatment Centers in Sub-Saharan Africa.
    Emerg Infect Dis. 2020;26.
    PubMed    
    
    
    November 2020
13. HALEY CA, Macias P, Jasuja S, Jones BA, et al
    Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available
    
    
    
14. HOPEWELL PC, Reichman LB, Castro KG
    Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and Control.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available
    
    
    September 2020
15. HOMOLKA S, Paulowski L, Andres S, Hillemann D, et al
    Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
16. MIGLIORI GB, Thong PM, Akkerman O, Alffenaar JW, et al
    Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
17. JENKS JD, Garfein RS, Zhu W, Hogarth M, et al
    Latent Tuberculosis Screening Using Electronic Health Record Data.
    Emerg Infect Dis. 2020;26:2285-2287.
    PubMed     Abstract available
    
    
    August 2020
18. LAMB GS, Cruz AT, Camp EA, Javier M, et al
    Tuberculosis in Internationally Displaced Children Resettling in Harris County, Texas, USA, 2010-2015(1).
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
19. JASPARD M, Butel N, El Helali N, Marigot-Outtandy D, et al
    Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.
    Emerg Infect Dis. 2020;26:1792-1800.
    PubMed     Abstract available
    
    
    July 2020
20. KWAK N, Hwang SS, Yim JJ
    Effect of COVID-19 on Tuberculosis Notification, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
21. THAM SM, Lim WY, Lee CK, Loh J, et al
    Four Patients with COVID-19 and Tuberculosis, Singapore, April-May 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
22. YAO Z, Chen J, Wang Q, Liu W, et al
    Three Patients with COVID-19 and Pulmonary Tuberculosis, Wuhan, China, January-February 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
23. SAAD J, Baron S, Lagier JC, Drancourt M, et al
    Mycobacterium bovis Pulmonary Tuberculosis after Ritual Sheep Sacrifice in Tunisia.
    Emerg Infect Dis. 2020;26:1605-1607.
    PubMed     Abstract available
    
    
    May 2020
24. BAIK Y, Modongo C, Moonan PK, Click ES, et al
    Possible Transmission Mechanisms of Mixed Mycobacterium tuberculosis Infection in High HIV Prevalence Country, Botswana.
    Emerg Infect Dis. 2020;26:953-960.
    PubMed     Abstract available
    
    
    
25. RATHI P, Shringarpure K, Unnikrishnan B, Chadha VK, et al
    Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017.
    Emerg Infect Dis. 2020;26:989-992.
    PubMed     Abstract available
    
    
    
26. HORTON KC, Hoey AL, Beraud G, Corbett EL, et al
    Systematic Review and Meta-Analysis of Sex Differences in Social Contact Patterns and Implications for Tuberculosis Transmission and Control.
    Emerg Infect Dis. 2020;26:910-919.
    PubMed     Abstract available
    
    
    
27. MOONAN PK, Zetola NM, Tobias JL, Basotli J, et al
    A Neighbor-Based Approach to Identify Tuberculosis Exposure, the Kopanyo Study.
    Emerg Infect Dis. 2020;26:1010-1013.
    PubMed     Abstract available
    
    
    April 2020
28. VAN DEN BOOGAARD J, Slump E, Schimmel HJ, van der Hoek W, et al
    High Incidence of Active Tuberculosis in Asylum Seekers from Eritrea and Somalia in the First 5 Years after Arrival in the Netherlands.
    Emerg Infect Dis. 2020;26:675-681.
    PubMed     Abstract available
    
    
    March 2020
29. CAMPBELL JR, Falzon D, Mirzayev F, Jaramillo E, et al
    Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
30. GETAHUN M, Blumberg HM, Sinshaw W, Diriba G, et al
    Low Prevalence of Mycobacterium bovis in Tuberculosis Patients, Ethiopia.
    Emerg Infect Dis. 2020;26:613-615.
    PubMed     Abstract available
    
    
    
31. ZHANG G, Zhang Y, Zhong D, Meng S, et al
    High Prevalence of and Risk Factors for Latent Tuberculosis Infection among Prisoners, Tianjin, China.
    Emerg Infect Dis. 2020;26:516-522.
    PubMed     Abstract available
    
    
    
32. MERKER M, Nikolaevskaya E, Kohl TA, Molina-Moya B, et al
    Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
    Emerg Infect Dis. 2020;26:481-490.
    PubMed     Abstract available
    
    
    
33. TSANG CA, Langer AJ, Kammerer JS, Navin TR, et al
    US Tuberculosis Rates among Persons Born Outside the United States Compared with Rates in Their Countries of Birth, 2012-2016(1).
    Emerg Infect Dis. 2020;26:533-540.
    PubMed     Abstract available
    
    
    
34. TIBBETTS KK, Ottoson RA, Tsukayama DT
    Public Health Response to Tuberculosis Outbreak among Persons Experiencing Homelessness, Minneapolis, Minnesota, USA, 2017-2018.
    Emerg Infect Dis. 2020;26:420-426.
    PubMed     Abstract available
    
    
    
35. HUANG CC, Chu AL, Becerra MC, Galea JT, et al
    Mycobacterium tuberculosis Beijing Lineage and Risk for Tuberculosis in Child Household Contacts, Peru.
    Emerg Infect Dis. 2020;26:568-578.
    PubMed     Abstract available
    
    
    
36. SHUAIB YA, Khalil EAG, Wieler LH, Schaible UE, et al
    Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan(1).
    Emerg Infect Dis. 2020;26:427-436.
    PubMed     Abstract available
    
    
    
37. KERR TJ, Gumbo R, Goosen WJ, Rogers P, et al
    Novel Techniques for Detection of Mycobacterium bovis Infection in a Cheetah.
    Emerg Infect Dis. 2020;26:630-631.
    PubMed     Abstract available
    
    
    
38. POORANSINGH S, Sakhamuri S
    Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations.
    Emerg Infect Dis. 2020;26:624-625.
    PubMed     Abstract available
    
    
    November 2019
39. BAFFOE-BONNIE A, Houpt ER, Turner L, Dodge D, et al
    Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient.
    Emerg Infect Dis. 2019;25.
    PubMed     Abstract available
    
    
    
40. FELLAG M, Saad J, Armstrong N, Chabriere E, et al
    Routine Culture-Resistant Mycobacterium tuberculosis Rescue and Shell-Vial Assay, France.
    Emerg Infect Dis. 2019;25:2131-2133.
    PubMed     Abstract available
    
    
    October 2019
41. SAKHAEE F, Vaziri F, Bahramali G, Taremian K, et al
    Pulmonary Infection Associated with Mycobacterium canariasense in Suspected Tuberculosis Patient, Iran.
    Emerg Infect Dis. 2019;25:1984-1986.
    PubMed     Abstract available
    
    
    
42. VONNAHME LA, Haddad MB, Navin TR
    Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011-2012.
    Emerg Infect Dis. 2019;25:1949-1951.
    PubMed     Abstract available
    
    
    
43. MURRAY KO, Castillo-Carandang NT, Mandalakas AM, Cruz AT, et al
    Prevalence of Tuberculosis in Children After Natural Disasters, Bohol, Philippines.
    Emerg Infect Dis. 2019;25:1884-1892.
    PubMed     Abstract available
    
    
    September 2019
44. KUMAR A, Kunoor A, Eapen M, Singh PK, et al
    Blastomycosis Misdiagnosed as Tuberculosis, India.
    Emerg Infect Dis. 2019;25:1776-1777.
    PubMed     Abstract available
    
    
    
45. SINGH PK, Jain A
    Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone.
    Emerg Infect Dis. 2019;25:1760-1762.
    PubMed     Abstract available
    
    
    July 2019
46. HUANG F, van den Hof S, Qu Y, Li Y, et al
    Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear-Negative Drug-Resistant Tuberculosis, China.
    Emerg Infect Dis. 2019;25:1289-1296.
    PubMed     Abstract available
    
    
    
47. BRODE SK, Chung H, Campitelli MA, Kwong JC, et al
    Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001-2013.
    Emerg Infect Dis. 2019;25.
    PubMed     Abstract available
    
    
    
48. HIGGITT RL, Louis van Schalkwyk O, de Klerk-Lorist LM, Buss PE, et al
    Mycobacterium bovis Infection in African Wild Dogs, Kruger National Park, South Africa.
    Emerg Infect Dis. 2019;25:1425-1427.
    PubMed     Abstract available
    
    
    May 2019
49. MBUAGBAW L, Guglielmetti L, Hewison C, Bakare N, et al
    Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2019;25:936-943.
    PubMed     Abstract available
    
    
    
50. PAUDEL S, Nakajima C, Mikota SK, Gairhe KP, et al
    Mixed Mycobacterium tuberculosis Lineage Infection in 2 Elephants, Nepal.
    Emerg Infect Dis. 2019;25:1031-1032.
    PubMed     Abstract available
    
    
    
51. LUIS BAL, Diaz-Lomeli P, Gomez-Albarran LP, Martinez-Gamboa A, et al
    Mycobacterium obuense Bacteremia in a Patient with Pneumonia.
    Emerg Infect Dis. 2019;25:1015-1016.
    PubMed     Abstract available
    
    
    April 2019
52. CAMPBELL JR, Johnston JC, Cook VJ, Sadatsafavi M, et al
    Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.
    Emerg Infect Dis. 2019;25:661-671.
    PubMed     Abstract available
    
    
    March 2019
53. HOLLAND DP, Alexander S, Onwubiko U, Goswami ND, et al
    Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015-2017.
    Emerg Infect Dis. 2019;25:593-595.
    PubMed     Abstract available
    
    
    
54. LOVEDAY M, Hlangu S, Furin J
    Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis.
    Emerg Infect Dis. 2019;25:609-610.
    PubMed     Abstract available
    
    
    
55. GENESTET C, Tatai C, Berland JL, Claude JB, et al
    Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018.
    Emerg Infect Dis. 2019;25:589-592.
    PubMed     Abstract available
    
    
    
56. SKIBA Y, Mokrousov I, Nabirova D, Vyazovaya A, et al
    Mycobacterium tuberculosis RD-Rio Strain in Kazakhstan.
    Emerg Infect Dis. 2019;25:604-606.
    PubMed     Abstract available
    
    
    
57. WANSAULA Z, Wortham JM, Mindra G, Haddad MB, et al
    Bacillus Calmette-Guerin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004-2015.
    Emerg Infect Dis. 2019;25:451-456.
    PubMed     Abstract available
    
    
    
58. PANG Y, An J, Shu W, Huo F, et al
    Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008-2017.
    Emerg Infect Dis. 2019;25:457-464.
    PubMed     Abstract available
    
    
    
59. OSMAN M, Harausz EP, Garcia-Prats AJ, Schaaf HS, et al
    Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis.
    Emerg Infect Dis. 2019;25:441-450.
    PubMed     Abstract available
    
    
    
60. CRUZ AT, Starke JR
    Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017.
    Emerg Infect Dis. 2019;25:523-528.
    PubMed     Abstract available
    
    
    
61. BAINOMUGISA A, Pandey S, Donnan E, Simpson G, et al
    Cross-Border Movement of Highly Drug-Resistant Mycobacterium tuberculosis from Papua New Guinea to Australia through Torres Strait Protected Zone, 2010-2015.
    Emerg Infect Dis. 2019;25:406-415.
    PubMed     Abstract available
    
    
    
62. DOMINGUEZ J, Acosta F, Perez-Lago L, Sambrano D, et al
    Simplified Model to Survey Tuberculosis Transmission in Countries Without Systematic Molecular Epidemiology Programs.
    Emerg Infect Dis. 2019;25:507-514.
    PubMed     Abstract available
    
    
    
63. ARANDJELOVIC I, Merker M, Richter E, Kohl TA, et al
    Longitudinal Outbreak of Multidrug-Resistant Tuberculosis in a Hospital Setting, Serbia.
    Emerg Infect Dis. 2019;25:555-558.
    PubMed     Abstract available
    
    
    
64. BOUZOUITA I, Cabibbe AM, Trovato A, Daroui H, et al
    Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016.
    Emerg Infect Dis. 2019;25:538-546.
    PubMed     Abstract available
    
    
    
65. LIPWORTH S, Jajou R, de Neeling A, Bradley P, et al
    SNP-IT Tool for Identifying Subspecies and Associated Lineages of Mycobacterium tuberculosis Complex.
    Emerg Infect Dis. 2019;25:482-488.
    PubMed     Abstract available
    
    
    
66. EL ACHKAR S, Demanche C, Osman M, Rafei R, et al
    Drug-Resistant Tuberculosis, Lebanon, 2016 - 2017.
    Emerg Infect Dis. 2019;25:564-568.
    PubMed     Abstract available
    
    
    
67. ACOSTA F, Agapito J, Cabibbe AM, Caceres T, et al
    Exportation of MDR TB to Europe from Setting with Actively Transmitted Persistent Strains in Peru.
    Emerg Infect Dis. 2019;25:596-598.
    PubMed     Abstract available
    
    
    December 2018
68. MILLER MA, Buss P, Parsons SDC, Roos E, et al
    Conservation of White Rhinoceroses Threatened by Bovine Tuberculosis, South Africa, 2016-2017.
    Emerg Infect Dis. 2018;24:2373-2375.
    PubMed     Abstract available
    
    
    
69. SANTOS N, Nunes T, Fonseca C, Vieira-Pinto M, et al
    Spatial Analysis of Wildlife Tuberculosis Based on a Serologic Survey Using Dried Blood Spots, Portugal.
    Emerg Infect Dis. 2018;24:2169-2175.
    PubMed     Abstract available
    
    
    November 2018
70. KAYOMO MK, Hasker E, Aloni M, Nkuku L, et al
    Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo.
    Emerg Infect Dis. 2018;24:2029-2035.
    PubMed     Abstract available
    
    
    
71. NISHIMURA T, Ota M, Mori M, Hasegawa N, et al
    Estimating Latent Tuberculosis Infection Using Interferon-gamma Release Assay, Japan.
    Emerg Infect Dis. 2018;24:2111-2113.
    PubMed     Abstract available
    
    
    
72. AUNG HL, Nyunt WW, Fong Y, Russell B, et al
    Acquired Resistance to Antituberculosis Drugs.
    Emerg Infect Dis. 2018;24:2134.
    PubMed    
    
    
    October 2018
73. HADDAD MB, Raz KM, Lash TL, Hill AN, et al
    Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011-2015.
    Emerg Infect Dis. 2018;24:1930-1933.
    PubMed     Abstract available
    
    
    
74. GARFEIN RS, Liu L, Cuevas-Mota J, Collins K, et al
    Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA.
    Emerg Infect Dis. 2018;24:1806-1815.
    PubMed     Abstract available
    
    
    June 2018
75. MICHELET L, De Cruz K, Henault S, Tambosco J, et al
    Mycobacterium bovis Infection of Red Fox, France.
    Emerg Infect Dis. 2018;24:1150-1153.
    PubMed     Abstract available
    
    
    
76. SANTIN M, Barrabeig I, Malchair P, Gonzalez-Luquero L, et al
    Pulmonary Infections with Nontuberculous Mycobacteria, Catalonia, Spain, 1994-2014.
    Emerg Infect Dis. 2018;24:1091-1094.
    PubMed     Abstract available
    
    
    March 2018
77. NGUYEN DT, Teeter LD, Graves J, Graviss EA, et al
    Characteristics Associated with Negative Interferon-gamma Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013-2015.
    Emerg Infect Dis. 2018;24:534-540.
    PubMed     Abstract available
    
    
    
78. CHERNYAEVA E, Rotkevich M, Krasheninnikova K, Yurchenko A, et al
    Whole-Genome Analysis of Mycobacterium tuberculosis from Patients with Tuberculous Spondylitis, Russia.
    Emerg Infect Dis. 2018;24:579-583.
    PubMed     Abstract available
    
    
    
79. ALTHOMSONS SP, Hill AN, Harrist AV, France AM, et al
    Statistical Method to Detect Tuberculosis Outbreaks among Endemic Clusters in a Low-Incidence Setting.
    Emerg Infect Dis. 2018;24:573-575.
    PubMed     Abstract available
    
    
    
80. RANDO-SEGURA A, Aznar ML, Moreno MM, Espasa M, et al
    Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
    Emerg Infect Dis. 2018;24:569-572.
    PubMed     Abstract available
    
    
    
81. BRENT AJ, Nyundo C, Langat J, Mulunda C, et al
    Prospective Observational Study of Incidence and Preventable Burden of Childhood Tuberculosis, Kenya.
    Emerg Infect Dis. 2018;24:514-523.
    PubMed    
    
    
    
82. NAIK PR, Moonan PK, Nirgude AS, Shewade HD, et al
    Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India.
    Emerg Infect Dis. 2018;24:478-484.
    PubMed     Abstract available
    
    
    
83. YEN YF, Pan SW, Su VY, Chuang PH, et al
    Influenza Vaccination and Incident Tuberculosis among Elderly Persons, Taiwan(1).
    Emerg Infect Dis. 2018;24:498-505.
    PubMed     Abstract available
    
    
    
84. KLOTZ D, Barth SA, Baumgartner W, Hewicker-Trautwein M, et al
    Mycobacterium avium subsp. hominissuis Infection in a Domestic Rabbit, Germany.
    Emerg Infect Dis. 2018;24:596-598.
    PubMed     Abstract available
    
    
    
85. LOUTET MG, Davidson JA, Brown T, Dedicoat M, et al
    Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.
    Emerg Infect Dis. 2018;24:524-533.
    PubMed     Abstract available
    
    
    November 2017
86. NATHAVITHARANA RR, Shi CX, Chindelevitch L, Calderon R, et al
    Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru.
    Emerg Infect Dis. 2017;23:1887-1890.
    PubMed     Abstract available
    
    
    
87. TAO NN, He XC, Zhang XX, Liu Y, et al
    Drug-Resistant Tuberculosis among Children, China, 2006-2015.
    Emerg Infect Dis. 2017;23:1800-1805.
    PubMed     Abstract available
    
    
    October 2017
88. ACHAR J, Hewison C, Cavalheiro AP, Skrahina A, et al
    Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Abstract available
    
    
    
89. MARYANDYSHEV A, Pontali E, Tiberi S, Akkerman O, et al
    Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Abstract available
    
    
    
90. JASPARD M, Elefant-Amoura E, Melonio I, De Montgolfier I, et al
    Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.
    Emerg Infect Dis. 2017;23.
    PubMed     Abstract available
    
    
    March 2017
91. SETO J, Wada T, Suzuki Y, Ikeda T, et al
    Mycobacterium tuberculosis Transmission among Elderly Persons, Yamagata Prefecture, Japan, 2009-2015.
    Emerg Infect Dis. 2017;23:448-455.
    PubMed     Abstract available
    
    
    
92. MALM S, Linguissi LS, Tekwu EM, Vouvoungui JC, et al
    New Mycobacterium tuberculosis Complex Sublineage, Brazzaville, Congo.
    Emerg Infect Dis. 2017;23:423-429.
    PubMed     Abstract available
    
    
    
93. ADJEMIAN J, Frankland TB, Daida YG, Honda JR, et al
    Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.
    Emerg Infect Dis. 2017;23:439-447.
    PubMed     Abstract available
    
    
    
94. SCOTT C, Cavanaugh JS, Silk BJ, Ershova J, et al
    Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis.
    Emerg Infect Dis. 2017;23:456-462.
    PubMed     Abstract available
    
    
    
95. BOURDILLON PM, Goncalves CC, Pelissari DM, Arakaki-Sanchez D, et al
    Increase in Tuberculosis Cases among Prisoners, Brazil, 2009-20141.
    Emerg Infect Dis. 2017;23:496-499.
    PubMed     Abstract available
    
    
    
96. SIMPSON G, Zimmerman R, Shashkina E, Chen L, et al
    Mycobacterium tuberculosis Infection among Asian Elephants in Captivity.
    Emerg Infect Dis. 2017;23:513-516.
    PubMed     Abstract available
    
    
    
97. CHANDRANAIK BM, Shivashankar BP, Umashankar KS, Nandini P, et al
    Mycobacterium tuberculosis Infection in Free-Roaming Wild Asian Elephant.
    Emerg Infect Dis. 2017;23:555-557.
    PubMed     Abstract available
    
    
    
98. BENOIT SR, Gregg EW, Jonnalagadda S, Phares CR, et al
    Association of Diabetes and Tuberculosis Disease among US-Bound Adult Refugees, 2009-2014.
    Emerg Infect Dis. 2017;23:543-545.
    PubMed     Abstract available
    
    
    
99. ALLANA S, Shashkina E, Mathema B, Bablishvili N, et al
    pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.
    Emerg Infect Dis. 2017;23:491-495.
    PubMed     Abstract available
    
    
    
100. ZACHARIAH A, Pandiyan J, Madhavilatha GK, Mundayoor S, et al
     Mycobacterium tuberculosis in Wild Asian Elephants, Southern India.
     Emerg Infect Dis. 2017;23:504-506.
     PubMed     Abstract available
     
     
     
101. MILLER MA, Buss PE, van Helden PD, Parsons SD, et al
     Mycobacterium bovis in a Free-Ranging Black Rhinoceros, Kruger National Park, South Africa, 2016.
     Emerg Infect Dis. 2017;23:557-558.
     PubMed     Abstract available
     
     
     
102. DAVIDSON JA, Loutet MG, O'Connor C, Kearns C, et al
     Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.
     Emerg Infect Dis. 2017;23:377-386.
     PubMed     Abstract available
     
     
     
103. SURIE D, Fane O, Finlay A, Ogopotse M, et al
     Molecular, Spatial, and Field Epidemiology Suggesting TB Transmission in Community, Not Hospital, Gaborone, Botswana.
     Emerg Infect Dis. 2017;23:487-490.
     PubMed     Abstract available
     
     
     February 2017
104. DENNING DW, Perlin DS, Muldoon EG, Colombo AL, et al
     Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities.
     Emerg Infect Dis. 2017;23.
     PubMed     Abstract available
     
     
     December 2016
105. BARASONA JA, Acevedo P, Diez-Delgado I, Queiros J, et al
     Tuberculosis-Associated Death among Adult Wild Boars, Spain, 2009-2014.
     Emerg Infect Dis. 2016;22:2178-2180.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: